LRCX 10-Q:
extract
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ─────────────────────────────────────────────────────────────────────────────────────────── For the quarterly period ended September 27, 2026 or TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ──────────────────────────────────────────────────────────────────────────────────────────── For the transition period from to Commission file number 000-12933 ___________________________________________________________ LAM RESEARCH CORPORATION (Exact name of registrant as specified in its charter) ___________________________________________________________ Delaware 94-2634797 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 4650 Cushing Parkway, Fremont, California 94538 (Address of principal executive offices) (Zip Code) Registrant’s telephone number, including area code: ( 510 ) 572-0200 Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, Par Value $0.001 Per Share LRCX The Nasdaq Stock Market ────────────────────────────────────────────────────────────────────────────────────────────────────────────────── (Nasdaq Global Select Market) __________________________________________________ Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐ Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. Large accelerated filer Accelerated filer Non-accelerated filer Smaller reporting company ────────────────────────────────────────────────────────── Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒ As of October 20, 2026, the Registrant had 1,249,171 thousand shares of Common Stock outstanding. LAM RESEARCH CORPORATION TABLE OF CONTENTS Page No. PART I. Financial Information Item 1. Financial Statements (Unaudited): Condensed Consolidated Statements of Operations for the three months ended September 27, 2026, and September 28, 2025 4 Condensed Consolidated Statements of Comprehensive Income for the three months ended September 27, 2026, and September 28, 2025 5 Condensed Consolidated Balance Sheets as of September 27, 2026, and June 28, 2026 6 Condensed Consolidated Statements of Cash Flows for the three months ended September 27, 2026, and September 28, 2025 7 Condensed Consolidated Statements of Stockholders’ Equity for the three months ended September 27, 2026, and September 28, 2025 8 Notes to Condensed Consolidated Financial Statements 9 Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 16 Item 3. Quantitative and Qualitative Disclosures About Market Risk 22 Item 4. Controls and Procedures 23 PART II. Other Information Item 1. Legal Proceedings 24 Item 1A. Risk Factors 24 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 39 Item 3. Defaults Upon Senior Securities 39 Item 4. Mine Safety Disclosures 39 Item 5. Other Information 39 Item 6. Exhibits 40 Signatures 41 Table of Contents CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS This Quarterly Report on Form 10-Q (“Form 10-Q”) contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact contained in this report are forward-looking statements. In some cases, forward-looking statements can be identified by words such as “anticipate,” “assume,” “become,” “believe,” “can,” “commit,” “continue,” “could,” “depend,” “drive,” “estimate,” “expect,” “focus,” “forecast,” “future,” “goal,” “grow,” “increase,” “intend,” “likely,” “maintain,” “may,” “objective,” “ongoing,” “opportunity,” “plan,” “possible,” “potential,” “predict,” “probable,” “project,” “remain,” “require,” “seek,” “should,” “strategy,” “sustain,” “target,” “transition,” “will,” “would,” or variations of these words or other similar expressions. However, the absence of these words or similar expressions does not mean that a statement is not forward-looking. Forward-looking statements in this report include, but are not limited to, statements concerning: our future results of operations and financial condition; our commitment to driving semiconductor breakthroughs; trends related to demand for electronic systems, including for high performance, energy efficient and highly integrated semiconductor devices, semiconductor manufacturer adoption of vertical scaling and advanced integration approaches, technology inflections, including increasing manufacturing complexity and precision requirements, and demand for our technologies and services; our belief regarding our position in deposition, etch, and clean markets and perceived opportunities for sustainable differentiation for us due to several specified factors; our research and development strategy, and beliefs and expectations regarding perceived opportunities and continued investments in research and development; our stock repurchase program, including the performance of the September 2026 ASRs and the available amount under the program for repurchase, our capital allocation strategy, including our intention to pay quarterly dividends, our focus to return a portion of our free cash flow to stockholders over time through dividends and share repurchases, and expected sources of funds for capital return activities; continued growth of wafer fabrication investment in calendar year 2026, including the role of the artificial intelligence (“AI”) market in driving higher spending across both the memory and non-memory market segments; our belief regarding demand for semiconductors and technology inflections in the semiconductor industry driving sustainable growth and increasing market opportunities for our products and services in the deposition, etch, and clean businesses; customer investments driving demand for our products and services; beliefs, estimates, and assumptions relating to our significant accounting policies, including with respect to revenue recognition, inventory valuation, and income taxes; our expectations regarding the sufficiency of our liquidity to support our anticipated business activities through the next twelve months based on anticipated cash flows and our current business outlook; our ability to access the capital markets; the dependence of our liquidity on our future revenues and ability to manage costs; expectations regarding deferred revenue; our evaluation of uncertain tax positions and related effects if recognized; financial instruments and related fair value estimates and assumptions, and credit concentration risks; commitments and contingencies, including our beliefs regarding the materiality of legal proceedings and probability of a material loss; and other statements included in Part I, Item 2, “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” Part II, Item 1A, “Risk Factors,” and elsewhere in this Form 10-Q. These forward-looking statements are not a guarantee of future performance and involve a number of risks, uncertainties, and other factors that could cause our actual results or outcomes, or the timing of our results or outcomes, to differ materially from those expressed or implied in this Form 10-Q. Such risks, uncertainties, and other factors include, among others, the following: • our assumptions related to continued expansion of the wafer fabrication equipment market, growth of deposition and etch intensity, and scaling of our operations may prove invalid; • business, economic, political, and/or regulatory conditions in the consumer electronics industry, the semiconductor industry and the overall economy, including wafer fabrication equipment spending or demand related to artificial intelligence (“AI”), may deteriorate or change; • the actions, performance, or investment levels of our customers and competitors may be inconsistent with our expectations; • customer and product mix, including across market segments and geographical regions, may change; • we may be unable to realize the value of our products and technology, successfully commercialize new products and technologies, implement pricing initiatives, or execute on perceived opportunities; • we may be unable to achieve anticipated operational, manufacturing, supply chain, procurement, and scale efficiencies; • customer technology transitions, capacity expansions, and fab construction projects may have different timing or be less successful than we expect; • we may be unable to manage operating expenses effectively while continuing to invest in research and development (“R&D”), product innovation, customer support, and future growth opportunities; • trade regulations, export controls (including entity listings, end use/user controls, technology controls, and foreign direct product rules), tariffs, trade disputes, and other geopolitical developments may inhibit our ability to sell our products or services; • supply chain cost increases, tariffs, and other inflationary pressures may continue to impact our profitability; • supply chain disruptions or manufacturing capacity constraints may limit our ability to manufacture and sell our products; • natural and human-caused disasters, disease outbreaks, war, terrorism, political or governmental unrest or instability, or other events beyond our control may impact our operations and revenue in affected areas; and • the other factors described in Part I, Item 2, “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and Part II, Item 1A, “Risk Factors” of this Form 10-Q and other documents we file from time to time with the Securities and Exchange Commission (“SEC”). You should evaluate all forward-looking statements made in this Form 10-Q in the context of these risks, uncertainties, and other factors. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof and are based on our current beliefs, expectations, and assumptions about future events. Except as required by law, we do not undertake any obligation to revise or update these forward-looking statements as a result of events or circumstances that occur after the date of this report or to reflect the occurrence or effect of anticipated or unanticipated events. Lam Research Corporation 2027 Q1 10-Q 3 Table of Contents PART I. FINANCIAL INFORMATION ITEM 1. Financial Statements LAM RESEARCH CORPORATION CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (in thousands, except per share data) (unaudited) Three Months Ended ──────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────── September 27, September 28, 2026 2025 Revenue $ 8,219,418 $ 5,324,173 Cost of goods sold 3,920,565 2,639,294 Gross margin 4,298,853 2,684,879 Research and development 666,398 576,446 Selling, general, and administrative 348,728 279,345 Total operating expenses 1,015,126 855,791 Operating income 3,283,727 1,829,088 Other income (expense), net 28,493 30,074 Income before income taxes 3,312,220 1,859,162 Income tax expense (559,082) (290,502) Net income $ 2,753,138 $ 1,568,660 Net income per share: Basic $ 2.20 $ 1.24 Diluted $ 2.19 $ 1.24 Number of shares used in per share calculations: Basic 1,250,883 1,264,446 Diluted 1,255,768 1,269,313 See Notes to Condensed Consolidated Financial Statements Lam Research Corporation 2027 Q1 10-Q 4 LAM RESEARCH CORPORATION CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (in thousands) (unaudited) Three Months Ended ───────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────── September 27, September 28, 2026 2025 Net income $ 2,753,138 $ 1,568,660 Other comprehensive income (loss), net of tax: Foreign currency translation adjustment 9,829 (12,726) Cash flow hedges: Net unrealized (losses) gains during the period (3,695) 8,570 Net gains reclassified into net income (6,421) (7,095) (10,116) 1,475 Defined benefit plans, net change in unrealized component 90 83 Other comprehensive income (loss), net of tax (197) (11,168) Comprehensive income $ 2,752,941 $ 1,557,492 See Notes to Condensed Consolidated Financial Statements Lam Research Corporation 2027 Q1 10-Q 5 LAM RESEARCH CORPORATION CONDENSED CONSOLIDATED BALANCE SHEETS (in thousands, except per share data) September 27, June 28, 2026 2026 (unaudited) (1) ASSETS Cash and cash equivalents $ 7,437,384 $ 5,579,171 Accounts receivable, less allowance of $8,358 as of September 27, 2026, and $8,071 as of June 28, 2026 5,658,379 5,339,682 Inventories 4,550,544 4,276,111 Prepaid expenses and other current assets 477,805 415,741 Total current assets 18,124,112 15,610,705 Property and equipment, net 3,126,029 2,956,472 Goodwill and intangible assets, net 1,911,547 1,895,859 Other assets 3,191,368 3,066,707 Total assets $ 26,353,056 $ 23,529,743 LIABILITIES AND STOCKHOLDERS’ EQUITY Trade accounts payable $ 1,592,208 $ 1,302,467 Accrued expenses and other current liabilities 3,287,463 2,351,541 Deferred profit 2,429,342 2,279,168 Current portion of long-term debt and finance lease obligations 3,486 4,073 Total current liabilities 7,312,499 5,937,249 Long-term debt and finance lease obligations 3,731,958 3,730,490 Income taxes payable 684,273 681,197 Other long-term liabilities 715,852 709,886 Total liabilities 12,444,582 11,058,822 Commitments and contingencies (refer to Note 12) Stockholders’ equity: Preferred stock, at par value of $0.001 per share; authorized, 5,000 shares, none outstanding — — Common stock, at par value of $0.001 per share; authorized, 4,000,000 shares as of September 27, 2026 and June 28, 2026; issued and outstanding, 1,249,145 shares as of September 27, 2026, and 1,251,278 shares as of June 28, 2026 1,249 1,251 Additional paid-in capital 9,363,408 9,244,449 Treasury stock, at cost; 1,712,490 shares as of September 27, 2026, and 1,710,109 shares as of June 28, 2026 (32,620,072) (31,597,945) Accumulated other comprehensive loss (127,285) (127,088) Retained earnings 37,291,174 34,950,254 Total stockholders’ equity 13,908,474 12,470,921 Total liabilities and stockholders’ equity $ 26,353,056 $ 23,529,743 (1)Derived from audited financial statements See Notes to Condensed Consolidated Financial Statements Lam Research Corporation 2027 Q1 10-Q 6 LAM RESEARCH CORPORATION CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (in thousands) (unaudited) Three Months Ended ───────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────── September 27, September 28, 2026 2025 CASH FLOWS FROM OPERATING ACTIVITIES: Net income $ 2,753,138 $ 1,568,660 Adjustments to reconcile net income to net cash provided by operating activities: Depreciation and amortization 122,072 101,644 Deferred income taxes (55,300) (62,875) Equity-based compensation expense 114,696 97,241 Other, net 27,633 (1,890) Changes in operating assets and liabilities 535,413 76,184 Net cash provided by operating activities 3,497,652 1,778,964 CASH FLOWS FROM INVESTING ACTIVITIES: Capital expenditures and intangible assets (257,697) (185,121) Other, net (9,292) (927) Net cash used for investing activities (266,989) (186,048) CASH FLOWS FROM FINANCING ACTIVITIES: Principal payments on debt, including finance lease obligations and payments for debt issuance costs (34,489) (1,417) Treasury stock purchases, including excise tax payments (1,024,965) (975,791) Dividends paid (325,402) (291,981) Proceeds from issuance of common stock, net of issuance costs 4,263 — Other, net (1,786) (12,449) Net cash used for financing activities (1,382,379) (1,281,638) Effect of exchange rate changes on cash, cash equivalents, and restricted cash 4,663 (7,059) Net change in cash, cash equivalents, and restricted cash 1,852,947 304,219 Cash, cash equivalents, and restricted cash at beginning of period (1) 5,597,943 6,407,656 Cash, cash equivalents, and restricted cash at end of period (1) $ 7,450,890 $ 6,711,875 Schedule of non-cash transactions: Accrued payables for stock repurchases, including applicable excise tax $ 31,512 $ 58,827 Accrued payables for capital expenditures 141,965 95,745 Dividends payable 412,218 327,507 Transfers of finished goods inventory to property and equipment 37,053 22,897 Reconciliation of cash, cash equivalents, and restricted cash September 27, September 28, 2026 2025 Cash and cash equivalents $ 7,437,384 $ 6,693,046 Restricted cash and cash equivalents (1) 13,506 18,829 Total cash, cash equivalents, and restricted cash $ 7,450,890 $ 6,711,875 (1)Restricted cash is reported within Other assets in the Condensed Consolidated Balance Sheets See Notes to Condensed Consolidated Financial Statements Lam Research Corporation 2027 Q1 10-Q 7 LAM RESEARCH CORPORATION CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (in thousands) (unaudited) Three Months Ended September 27, 2026 Common Common Additional Treasury Accumulated Retained Total Stock Stock Paid-in Stock Other Earnings Shares Capital Comprehensive Loss ───────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────── Balance at June 28, 2026 1,251,278 $ 1,251 $ 9,244,449 $ (31,597,945) $ (127,088) $ 34,950,254 $ 12,470,921 Issuance of common stock 248 — 4,263 — — — 4,263 Purchase of treasury stock (2,381) (2) — (1,022,127) — — (1,022,129) Equity-based compensation expense — — 114,696 — — — 114,696 Net income — — — — — 2,753,138 2,753,138 Other comprehensive loss — — — — (197) — (197) Cash dividends declared ($0.33 per common share) — — — — — (412,218) (412,218) Balance at September 27, 2026 1,249,145 $ 1,249 $ 9,363,408 $ (32,620,072) $ (127,285) $ 37,291,174 $ 13,908,474 Three Months Ended September 28, 2025 Common Common Additional Treasury Accumulated Retained Total Stock Stock Paid-in Stock Other Earnings Shares Capital Comprehensive Loss Balance at June 29, 2025 1,268,740 $ 1,268 $ 8,697,290 $ (27,763,430) $ (62,423) $ 28,988,914 $ 9,861,619 Issuance of common stock 178 — — — — — — Purchase of treasury stock (9,742) (10) — (996,083) — — (996,093) Equity-based compensation expense — — 97,241 — — — 97,241 Net income — — — — — 1,568,660 1,568,660 Other comprehensive loss — — — — (11,168) — (11,168) Cash dividends declared ($0.26 per common share) — — — — — (327,507) (327,507) Balance at September 28, 2025 1,259,176 $ 1,258 $ 8,794,531 $ (28,759,513) $ (73,591) $ 30,230,067 $ 10,192,752 See Notes to Condensed Consolidated Financial Statements Lam Research Corporation 2027 Q1 10-Q 8 LAM RESEARCH CORPORATION NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS September 27, 2026 (Unaudited) NOTE 1 - BASIS OF PRESENTATION The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information and the instructions to Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for annual financial statements. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair presentation of the periods presented have been included. The accompanying unaudited Condensed Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements of Lam Research Corporation (“Lam Research” or the “Company”) for the fiscal year ended June 28, 2026, which are included in the Company’s Annual Report on Form 10-K as of and for the year ended June 28, 2026 (the “2026 Form 10-K”). The Condensed Consolidated Financial Statements include the accounts of Lam Research and its wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. The Company’s reporting period is a 52/53-week fiscal year. The Company’s current fiscal year will end June 27, 2027 and includes 52 weeks. The quarters ended September 27, 2026 and September 28, 2025 included 13 weeks. NOTE 2 - RECENT ACCOUNTING PRONOUNCEMENTS Recently Adopted or Effective The Company has not adopted any new accounting standards during the three months ended September 27, 2026 that have a material impact on the Company’s Condensed Consolidated Financial Statements. NOTE 3 - REVENUE Disaggregation of Revenue The Company operates in seven geographic regions: United States, China, Europe, Japan, Korea, Southeast Asia, and Taiwan. For geographical reporting, revenue is attributed to the geographic location in which the customers’ facilities are located. The Company serves three primary markets: memory, foundry, and logic/integrated device manufacturing. The following table presents the Company’s revenues disaggregated between systems and customer support-related revenue: Three Months Ended (in thousands) ──────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────── September 27, September 28, 2026 2025 Systems revenue $ 5,732,907 $3,547,565 Customer support-related revenue and other 2,486,511 1,776,608 $ 8,219,418 $5,324,173 Systems revenue includes sales of new leading-edge equipment in deposition, etch, clean and other wafer fabrication markets. Customer support-related revenue includes sales of customer services, spares, upgrades, and non-leading-edge equipment from the Company’s Reliant® product line. Lam Research Corporation 2027 Q1 10-Q 9 The following table presents the Company’s revenues disaggregated by geographic region: Three Months Ended Revenue: (in thousands) ─────────────────────────────────────────────────────────────────────────────────────────────────────────────── September 27, September 28, 2026 2025 China $ 2,885,608 $ 2,282,573 Korea 1,634,115 776,301 Taiwan 1,482,087 1,027,214 Japan 721,509 529,297 United States 663,102 304,716 Southeast Asia 531,694 302,254 Europe 301,303 101,818 $ 8,219,418 $ 5,324,173 The following table presents the percentages of leading- and non-leading-edge equipment and upgrade revenue to each of the primary markets the Company serves: Three Months Ended ─────────────────────────────────────────────────────────────────────────────────────────────────────── September 27, September 28, 2026 2025 Foundry 46% 60% Memory 46% 34% Logic/integrated device manufacturing 8% 6% Deferred Revenue Revenue of $ 901.2 million included in deferred profit at June 28, 2026 was recognized during the three months ended September 27, 2026, representing 37 % of the $ 2.43 billion of deferred revenue as of June 28, 2026. The following table summarizes the transaction price for contracts that have not yet been recognized as revenue as of September 27, 2026 and when the Company expects to recognize the amounts as revenue: Less than 1 Year 1-3 Years More than 3 Years Total (in thousands) ───────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────── Deferred revenue $ 2,026,932 $539,916 (1) $94,383 (1) $2,661,231 (1) This amount is reported in Deferred profit on the Company's Condensed Consolidated Balance Sheets as the customers can demand the performance to be satisfied at any time. NOTE 4 - EQUITY-BASED COMPENSATION PLANS The Lam Research Corporation 2015 Stock Incentive Plan, as amended, and the Lam Research Corporation 2025 Stock Incentive Plan provide for the grant of non-qualified equity-based awards of the Company’s Common Stock to eligible employees and non-employee directors, including stock options, restricted stock units (“RSUs”), and market-based performance RSUs (“market-based PRSUs”). An option is a right to purchase Common Stock at a set price. An RSU award is an agreement to issue a set number of shares of Common Stock at the time of vesting. The Company’s market-based PRSUs contain both a market condition and a service condition. The Company’s option, RSU, and market-based PRSU awards typically vest over a period of three years. The Company also has an employee stock purchase plan that allows eligible employees to purchase its Common Stock at a discount through payroll deductions. The Company recognized the following equity-based compensation expense (including expense related to the employee stock purchase plan) in the Condensed Consolidated Statements of Operations: Three Months Ended (in thousands) ───────────────────────────────────────────────────────────────────────────────────────────────────────────────── September 27, September 28, 2026 2025 Equity-based compensation expense $ 114,696 $97,241 Lam Research Corporation 2027 Q1 10-Q 10 NOTE 5 - OTHER INCOME (EXPENSE), NET The significant components of other income (expense), net, are as follows: Three Months Ended (in thousands) ──────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
retained text (truncated)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
───────────────────────────────────────────────────────────────────────────────────────────
For the quarterly period ended September 27, 2026
or
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
────────────────────────────────────────────────────────────────────────────────────────────
For the transition period from to
Commission file number 000-12933
___________________________________________________________
LAM RESEARCH CORPORATION
(Exact name of registrant as specified in its charter)
___________________________________________________________
Delaware 94-2634797
(State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.)
4650 Cushing Parkway, Fremont, California 94538
(Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code: ( 510 ) 572-0200
Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, Par Value $0.001 Per Share LRCX The Nasdaq Stock Market
──────────────────────────────────────────────────────────────────────────────────────────────────────────────────
(Nasdaq Global Select Market)
__________________________________________________
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer Accelerated filer
Non-accelerated filer Smaller reporting company
──────────────────────────────────────────────────────────
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
As of October 20, 2026, the Registrant had 1,249,171 thousand shares of Common Stock outstanding.
LAM RESEARCH CORPORATION
TABLE OF CONTENTS
Page No.
PART I. Financial Information
Item 1. Financial Statements (Unaudited):
Condensed Consolidated Statements of Operations for the three months ended September 27, 2026, and September 28, 2025 4
Condensed Consolidated Statements of Comprehensive Income for the three months ended September 27, 2026, and September 28, 2025 5
Condensed Consolidated Balance Sheets as of September 27, 2026, and June 28, 2026 6
Condensed Consolidated Statements of Cash Flows for the three months ended September 27, 2026, and September 28, 2025 7
Condensed Consolidated Statements of Stockholders’ Equity for the three months ended September 27, 2026, and September 28, 2025 8
Notes to Condensed Consolidated Financial Statements 9
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 16
Item 3. Quantitative and Qualitative Disclosures About Market Risk 22
Item 4. Controls and Procedures 23
PART II. Other Information
Item 1. Legal Proceedings 24
Item 1A. Risk Factors 24
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 39
Item 3. Defaults Upon Senior Securities 39
Item 4. Mine Safety Disclosures 39
Item 5. Other Information 39
Item 6. Exhibits 40
Signatures 41
Table of Contents
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS
This Quarterly Report on Form 10-Q (“Form 10-Q”) contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact contained in this report are forward-looking statements. In some cases, forward-looking statements can be identified by words such as “anticipate,” “assume,” “become,” “believe,” “can,” “commit,” “continue,” “could,” “depend,” “drive,” “estimate,” “expect,” “focus,” “forecast,” “future,” “goal,” “grow,” “increase,” “intend,” “likely,” “maintain,” “may,” “objective,” “ongoing,” “opportunity,” “plan,” “possible,” “potential,” “predict,” “probable,” “project,” “remain,” “require,” “seek,” “should,” “strategy,” “sustain,” “target,” “transition,” “will,” “would,” or variations of these words or other similar expressions. However, the absence of these words or similar expressions does not mean that a statement is not forward-looking. Forward-looking statements in this report include, but are not limited to, statements concerning: our future results of operations and financial condition; our commitment to driving semiconductor breakthroughs; trends related to demand for electronic systems, including for high performance, energy efficient and highly integrated semiconductor devices, semiconductor manufacturer adoption of vertical scaling and advanced integration approaches, technology inflections, including increasing manufacturing complexity and precision requirements, and demand for our technologies and services; our belief regarding our position in deposition, etch, and clean markets and perceived opportunities for sustainable differentiation for us due to several specified factors; our research and development strategy, and beliefs and expectations regarding perceived opportunities and continued investments in research and development; our stock repurchase program, including the performance of the September 2026 ASRs and the available amount under the program for repurchase, our capital allocation strategy, including our intention to pay quarterly dividends, our focus to return a portion of our free cash flow to stockholders over time through dividends and share repurchases, and expected sources of funds for capital return activities; continued growth of wafer fabrication investment in calendar year 2026, including the role of the artificial intelligence (“AI”) market in driving higher spending across both the memory and non-memory market segments; our belief regarding demand for semiconductors and technology inflections in the semiconductor industry driving sustainable growth and increasing market opportunities for our products and services in the deposition, etch, and clean businesses; customer investments driving demand for our products and services; beliefs, estimates, and assumptions relating to our significant accounting policies, including with respect to revenue recognition, inventory valuation, and income taxes; our expectations regarding the sufficiency of our liquidity to support our anticipated business activities through the next twelve months based on anticipated cash flows and our current business outlook; our ability to access the capital markets; the dependence of our liquidity on our future revenues and ability to manage costs; expectations regarding deferred revenue; our evaluation of uncertain tax positions and related effects if recognized; financial instruments and related fair value estimates and assumptions, and credit concentration risks; commitments and contingencies, including our beliefs regarding the materiality of legal proceedings and probability of a material loss; and other statements included in Part I, Item 2, “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” Part II, Item 1A, “Risk Factors,” and elsewhere in this Form 10-Q.
These forward-looking statements are not a guarantee of future performance and involve a number of risks, uncertainties, and other factors that could cause our actual results or outcomes, or the timing of our results or outcomes, to differ materially from those expressed or implied in this Form 10-Q. Such risks, uncertainties, and other factors include, among others, the following:
• our assumptions related to continued expansion of the wafer fabrication equipment market, growth of deposition and etch intensity, and scaling of our operations may prove invalid;
• business, economic, political, and/or regulatory conditions in the consumer electronics industry, the semiconductor industry and the overall economy, including wafer fabrication equipment spending or demand related to artificial intelligence (“AI”), may deteriorate or change;
• the actions, performance, or investment levels of our customers and competitors may be inconsistent with our expectations;
• customer and product mix, including across market segments and geographical regions, may change;
• we may be unable to realize the value of our products and technology, successfully commercialize new products and technologies, implement pricing initiatives, or execute on perceived opportunities;
• we may be unable to achieve anticipated operational, manufacturing, supply chain, procurement, and scale efficiencies;
• customer technology transitions, capacity expansions, and fab construction projects may have document fetched 2026-10-24 11:18 · canonical https://sec.gov/Archives/edgar/data/707549/000070754926000054/lrcx-20260927.htm